Allogeneic dopaminergic neural precursor cell(iDAP) therapy(Anhui Provincial Hospital)

N/A

Report date: 2024/09/06 20:00:43

Base Information

Drug NameAllogeneic dopaminergic neural precursor cell(iDAP) therapy(Anhui Provincial Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnhui Provincial Hospital
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Provincial Hospital
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A